ES2054754T3 - Analogos ciclicos del grf. - Google Patents

Analogos ciclicos del grf.

Info

Publication number
ES2054754T3
ES2054754T3 ES88114948T ES88114948T ES2054754T3 ES 2054754 T3 ES2054754 T3 ES 2054754T3 ES 88114948 T ES88114948 T ES 88114948T ES 88114948 T ES88114948 T ES 88114948T ES 2054754 T3 ES2054754 T3 ES 2054754T3
Authority
ES
Spain
Prior art keywords
cyclical
analogs
grf
stimulate
subjects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88114948T
Other languages
English (en)
Inventor
Arthur Martin Felix
Edgar Philip Heimer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2054754T3 publication Critical patent/ES2054754T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Led Devices (AREA)
  • Amplifiers (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

HORMONA DE CRECIMIENTO CICLICO Y LINEAL QUE LIBERA ANALOGOS FACTORES Y UN METODO PARA ESTIMULAR LA LIBERACION DE HORMONAS DE CRECIMIENTO EN SUJETOS POR ADMINISTRAR AL SUJETO UNA CANTIDAD EFECTIVA DE LOS COMPONENTES DEL INVENTO.
ES88114948T 1987-09-18 1988-09-13 Analogos ciclicos del grf. Expired - Lifetime ES2054754T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9834087A 1987-09-18 1987-09-18

Publications (1)

Publication Number Publication Date
ES2054754T3 true ES2054754T3 (es) 1994-08-16

Family

ID=22268851

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88114948T Expired - Lifetime ES2054754T3 (es) 1987-09-18 1988-09-13 Analogos ciclicos del grf.

Country Status (13)

Country Link
EP (1) EP0307860B1 (es)
JP (1) JP2715472B2 (es)
CN (1) CN1030255C (es)
AT (1) ATE106895T1 (es)
AU (1) AU609878B2 (es)
DE (1) DE3850015T2 (es)
DK (1) DK519088A (es)
ES (1) ES2054754T3 (es)
IE (1) IE64494B1 (es)
NZ (1) NZ226178A (es)
PH (1) PH25715A (es)
PT (1) PT88532B (es)
ZA (1) ZA886860B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026685A (en) * 1988-07-15 1991-06-25 The Salk Institute For Biological Studies NPY peptide analogs
US5043322A (en) * 1988-07-22 1991-08-27 The Salk Institute For Biological Studies Cyclic GRF analogs
US5084442A (en) * 1988-09-06 1992-01-28 Hoffmann-La Roche Inc. Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
US5756458A (en) * 1989-06-16 1998-05-26 Pharmacia & Upjohn Company Stabilized potent GRF analogs
EP0477217B1 (en) * 1989-06-16 1994-11-09 The Upjohn Company Stabilized, potent grf analogs
WO1996017941A2 (en) * 1994-12-07 1996-06-13 Bionebraska, Inc. Production of c-terminal amidated peptides from recombinant protein constructs
JP6113144B2 (ja) * 2011-04-21 2017-04-12 セラテクノロジーズ・インコーポレーテッド 成長ホルモン放出因子（ｇｒｆ）類似体およびその使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU575843B2 (en) * 1983-08-10 1988-08-11 The Administrators Of The Tulane Eductional Fund Growth hormone releasing peptides
US4528190A (en) * 1983-10-25 1985-07-09 The Salk Institute For Biological Studies GRF Analogs IV
CA1271600A (en) * 1985-01-07 1990-07-10 David Howard Coy Growth hormone-releasing peptides and method of treating mammals therewith
US5002931A (en) * 1987-05-22 1991-03-26 The Salk Institute For Biological Studies GRF analogs VII

Also Published As

Publication number Publication date
EP0307860B1 (en) 1994-06-08
DE3850015T2 (de) 1994-10-20
JPH01129000A (ja) 1989-05-22
IE882835L (en) 1989-03-18
CN1030255C (zh) 1995-11-15
NZ226178A (en) 1991-06-25
AU609878B2 (en) 1991-05-09
ZA886860B (en) 1989-05-30
PT88532B (pt) 1992-11-30
CN1032014A (zh) 1989-03-29
PT88532A (pt) 1988-10-01
DE3850015D1 (de) 1994-07-14
EP0307860A2 (en) 1989-03-22
IE64494B1 (en) 1995-08-09
JP2715472B2 (ja) 1998-02-18
PH25715A (en) 1991-09-18
EP0307860A3 (en) 1990-07-11
DK519088D0 (da) 1988-09-16
DK519088A (da) 1989-03-19
AU2234688A (en) 1989-03-23
ATE106895T1 (de) 1994-06-15

Similar Documents

Publication Publication Date Title
ES2187659T3 (es) Tratamiento de la diabetes mellitus de tipo ii con agonistas de amilina.
ES284421Y (es) Un dispositivo de vastago de embolo para utilizar con una j eringa.
DE3684220D1 (de) Zusammensetzung mit verzoegerter abgabe.
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
EP0365779A3 (en) Cyclic grf-analogs ii
BR8503622A (pt) Injetor para liberar uma dose predeterminada a um animal
ES2037385T3 (es) Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
ES2067231T3 (es) Formas de dosificado para suministrar un agente antiparkinson.
ES2530769T3 (es) Métodos para la activación de células T in vivo por células dendríticas pulsadas con antígeno
BR8306058A (pt) Seringa dentaria para injecoes intra-ligamentares
ES458760A1 (es) Procedimiento para fijar un manguito metalico a una barra derefuerzo de hormigon.
ES2050668T3 (es) Composiciones que mejoran la permeabilidad de la piel con el uso de monolaurato de glicerol.
ES2101106T3 (es) Metodo para estimular la respuesta inmunitaria.
ES2070244T3 (es) Preparado de hypericina.
DOP1982004152A (es) Peptidos sinteticos que tienen una accion liberadora de la hormona pituitaria del crecimiento
ES546137A0 (es) Procedimiento para la obtencion de un compuesto para antago-nizar la respuesta in vivo,de un animal,a la accion antidiu-retica de una hormona antidiuretica
DE3583887D1 (de) Ausruestung fuer die behandlung der osteoporose.
ES2073678T3 (es) Formulaciones radiofarmaceuticas, su metodo de administracion y procedimiento de preparacion.
ES2068705T3 (es) Tratamiento de la enfermedad neoplastica con interleuquina-10.
ES2070358T3 (es) Dispositivo para enclavar un espadin de aguja de ferrocarril.
ES2054754T3 (es) Analogos ciclicos del grf.
MX9203319A (es) Metodo para la preparacion de cristales de alfa-2 interferona.
ES2111163T3 (es) Uso de fosfonatos para el tratamiento de la osteoporosis.
ECSP034858A (es) Administración oral de hormona paratiroides y calcitonina
SE8802869L (sv) Kombination av pyrimidinderivat och retinoider som separata komponenter foer att inducera och stimulera haartillvaext och minska dess avfall

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 307860

Country of ref document: ES